EE43 Utilizing Real-World Evidence to Estimate Treatment Costs Among Norwegian Patients with Myasthenia Gravis Treated with Intravenous Immunoglobulin (IVIG)
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.316
https://www.valueinhealthjournal.com/article/S1098-3015(23)03446-0/fulltext
Title :
EE43 Utilizing Real-World Evidence to Estimate Treatment Costs Among Norwegian Patients with Myasthenia Gravis Treated with Intravenous Immunoglobulin (IVIG)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03446-0&doi=10.1016/j.jval.2023.09.316
First page :
Section Title :
Open access? :
No
Section Order :
12340